companydata.dkcompanydata.dk

STELLARIS PHARMACEUTICALS ApS: Financial statements 2014

CVR: 34708215

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -384,376. Equity in the 2014 report amounted to DKK -330,186.

Profit/Loss
DKK -384,376
Equity
DKK -330,186
Total Assets
DKK 54,155

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

STELLARIS PHARMACEUTICALS ApS publishes interim reportMay 23, 2014

STELLARIS PHARMACEUTICALS ApS has published its interim report for the period September 21, 2012 – December 31, 2013.

About STELLARIS PHARMACEUTICALS ApS

STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.

Source: annual report 2025, Danish Business Authority